Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 1997

View Archived Issues

87 development projects under way at Zeneca

New AmBisome data reported

SmithKline Beecham licenses rotavirus vaccine

Faropenem data presented at Japanese congress

Searle describes selective alphav/beta3 integrin antagonists

Natural anti-HIV agent disclosed by Hoechst

ViroPharma develops agents for HCV infection

5-HT receptor (ant)agonists from Pfizer

Selective COX-2 inhibitors under development at Merck Frosst

Second-generation antisense antitumor compound from Hybridon enters clinic

Aronex presents preliminary phase II results on Atragen

Pennsaid submitted to FDA for approval

CerAxon submitted for approval in U.S.

CB1 receptors are activated in hemorrhagic shock

FDA approves new alternative to hysterectomy in women with menorrhagia

Promising results reported from phase II trial for AIDS-related diarrhea

Oral morphine effective for management of sickle cell pain in children

ICAgen and Abbott join forces for ion channel research

Spotlight on ACE inhibitor/calcium antagonist combinations

Sagami discovers lead for potent and selective anti-H. pylori agents

Itraconazole maintenance therapy prevents relapse of histoplasmosis in AIDS

rhIL-11 reduces need for platelet transfusion in breast cancer patients on high-dose chemotherapy

Scherer-Sankyo Zydis formulation agreement

Orally activated protein therapy reported

Elan to acquire Sano in all-stock transaction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...